Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHA:600329)
42.22
+0.14 (0.33%)
Mar 20, 2026, 3:00 PM CST
33.82% (1Y)
| Market Cap | 28.53B +37.8% |
| Revenue (ttm) | 5.37B -33.3% |
| Net Income | 3.58B +283.7% |
| EPS | 4.66 +285.0% |
| Shares Out | 770.09M |
| PE Ratio | 9.04 |
| Forward PE | 13.93 |
| Dividend | 1.28 (2.96%) |
| Ex-Dividend Date | Feb 12, 2026 |
| Volume | 3,174,897 |
| Average Volume | 3,706,636 |
| Open | 42.19 |
| Previous Close | 42.08 |
| Day's Range | 42.13 - 43.00 |
| 52-Week Range | 28.53 - 50.97 |
| Beta | 0.78 |
| RSI | 44.60 |
| Earnings Date | Mar 31, 2026 |